Data on a new crop of hormone analogues for weight loss—including an oral version of semaglutide and the triple agent retatrutide—were recently presented at the American Diabetes Association’s annual Scientific Sessions. Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA’s Jennifer Abbasi about this and other clinical data presented at the meeting.  Related Content:  New Weight Loss Drugs Make Headlines at Diabetes Meeting 

Highlights From the American Diabetes Association Scientific Session 2023

Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.

Medicine

Science & Medicine

Science

Health & Fitness

Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A;, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations.  Related Content:  One Day, AI Could Mean Better Mental Health for All 

Enhancing Global Mental Health Care With Digital Tools and AI for Scalable Interventions

An Explosion of Food Is Medicine Research Could Change Health Care; Blockbuster Obesity Drugs Have Potential New Uses  Related Content:  Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? Produce Prescriptions Sound Good, but Data to Support Them Are Lacking—That Could Soon Change 

April 26, 2024, Medical News Summary

Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division.  Related Content:  Clinical Highlights From the American College of Cardiology’s 2024 Scientific Session 

Highlights From the American College of Cardiology’s 2024 Scientific Session

Momentum Grows for Disaggregated Asian American Health Data; What Clinicians Need to Know About TikTok  Related Content:  Researchers Are Working to Disaggregate Asian American Health Data—Here’s Why It’s Long Overdue Patients Are Turning to TikTok for Health Information—Here’s What Clinicians Need to Know 

April 12, 2024 Medical News Summary

Could generative AI assist in extending access to vulnerable populations and begin to bridge the gap in disparities? In this Q&A;, Davey Smith, MD, MAS, an infectious disease specialist and virologist at the University of California, San Diego, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to explore the implications of large language models for improving patient outcomes.  Related Content:  Will Generative AI Tools Improve Access to Reliable Health Information? 

Highlights From the American Diabetes Association Scientific Session 2023

Download our free app to listen on your phone